Last reviewed · How we verify
Zhi Kang Capsule
Zhi Kang Capsule is a traditional Chinese medicine formulation that modulates immune and inflammatory responses to support anti-cancer activity.
Zhi Kang Capsule is a traditional Chinese medicine formulation that modulates immune and inflammatory responses to support anti-cancer activity. Used for Adjunctive therapy in cancer treatment (specific cancer types not clearly defined in available literature).
At a glance
| Generic name | Zhi Kang Capsule |
|---|---|
| Sponsor | Peking University People's Hospital |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
The capsule contains herbal components traditionally used in Chinese medicine to enhance immune function and reduce inflammation. While the exact molecular mechanisms are not fully characterized in Western pharmacological terms, it is designed to work as an adjunctive therapy in cancer treatment by supporting the body's natural defense mechanisms and potentially enhancing the efficacy of conventional therapies.
Approved indications
- Adjunctive therapy in cancer treatment (specific cancer types not clearly defined in available literature)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Zhi Kang Capsule CI brief — competitive landscape report
- Zhi Kang Capsule updates RSS · CI watch RSS
- Peking University People's Hospital portfolio CI